These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 26159261)

  • 21. Drug-Induced Liver Injury: Highlights of the Recent Literature.
    Real M; Barnhill MS; Higley C; Rosenberg J; Lewis JH
    Drug Saf; 2019 Mar; 42(3):365-387. PubMed ID: 30343418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monocyte-derived hepatocyte-like cells for causality assessment of idiosyncratic drug-induced liver injury.
    Benesic A; Leitl A; Gerbes AL
    Gut; 2016 Sep; 65(9):1555-63. PubMed ID: 26045135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Art and Science of Diagnosing and Managing Drug-induced Liver Injury in 2015 and Beyond.
    Lewis JH
    Clin Gastroenterol Hepatol; 2015 Nov; 13(12):2173-89.e8. PubMed ID: 26116527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-induced liver injury and drug development: industry perspective.
    Regev A
    Semin Liver Dis; 2014 May; 34(2):227-39. PubMed ID: 24879986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of liver biopsy in the diagnosis of drug-induced liver injury.
    Ahmad J; Barnhart HX; Bonacini M; Ghabril M; Hayashi PH; Odin JA; Rockey DC; Rossi S; Serrano J; Tillmann HL; Kleiner DE;
    J Hepatol; 2022 May; 76(5):1070-1078. PubMed ID: 35074471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-induced liver injury: Pathogenesis, epidemiology, clinical features, and practical management.
    Björnsson HK; Björnsson ES
    Eur J Intern Med; 2022 Mar; 97():26-31. PubMed ID: 34772600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry.
    Stephens C; Robles-Diaz M; Medina-Caliz I; Garcia-Cortes M; Ortega-Alonso A; Sanabria-Cabrera J; Gonzalez-Jimenez A; Alvarez-Alvarez I; Slim M; Jimenez-Perez M; Gonzalez-Grande R; Fernández MC; Casado M; Soriano G; Román E; Hallal H; Romero-Gomez M; Castiella A; Conde I; Prieto M; Moreno-Planas JM; Giraldez A; Moreno-Sanfiel JM; Kaplowitz N; Lucena MI; Andrade RJ;
    J Hepatol; 2021 Jul; 75(1):86-97. PubMed ID: 33539847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Idiosyncratic drug-induced liver injury: an update on the 2007 overview.
    Hussaini SH; Farrington EA
    Expert Opin Drug Saf; 2014 Jan; 13(1):67-81. PubMed ID: 24073714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How to avoid being surprised by hepatotoxicity at the final stages of drug development and approval.
    Regev A
    Clin Liver Dis; 2013 Nov; 17(4):749-67, xi. PubMed ID: 24099029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An update on drug induced liver injury.
    Rangnekar AS; Fontana RJ
    Minerva Gastroenterol Dietol; 2011 Jun; 57(2):213-29. PubMed ID: 21587150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Avoidability of drug-induced liver injury (DILI) in an elderly hospital cohort with cases assessed for causality by the updated RUCAM score.
    Danjuma MI; Almasri H; Alshokri S; Khir FK; Elmalik A; Battikh NG; Abdallah IMH; Elshafei M; Fatima H; Mohamed MFH; Maghoub Y; Hussain T; Kamal I; Anwer Z; Bidmos MA; Elzouki AN
    BMC Geriatr; 2020 Sep; 20(1):346. PubMed ID: 32928134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of the revised electronic version of RUCAM for diagnosis of DILI in Chinese patients.
    Zhao X; Wang Y; Lai R; Wang X; Yu Y; Li M; Zhao H; Ma Z; Li M; Guo T; Han X; Meng Y; Zhang M; Su Y; Hao K; Deng Y; Kong Y; Li Z; Xie Q; Xie W; Chen C; Jia J
    Hepatol Commun; 2024 Apr; 8(4):. PubMed ID: 38466883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-induced liver injury: a summary of recent advances.
    Stine JG; Lewis JH
    Expert Opin Drug Metab Toxicol; 2011 Jul; 7(7):875-90. PubMed ID: 21510822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-induced liver injury: an overview over the most critical compounds.
    Björnsson ES
    Arch Toxicol; 2015 Mar; 89(3):327-34. PubMed ID: 25618544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Idiosyncratic Toxicology of Drugs in the Human Liver Compared with Animals: Basic Considerations.
    Teschke R
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Drug-induced liver injury].
    Björnsson ES
    Laeknabladid; 2010 Mar; 96(3):175-82. PubMed ID: 20197596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pathology of drug-induced liver injury.
    Kleiner DE
    Semin Liver Dis; 2009 Nov; 29(4):364-72. PubMed ID: 19826970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Evolving Profile of Idiosyncratic Drug-Induced Liver Injury.
    Fontana RJ; Bjornsson ES; Reddy R; Andrade RJ
    Clin Gastroenterol Hepatol; 2023 Jul; 21(8):2088-2099. PubMed ID: 36868489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-Induced Liver Injury (DILI) With Micafungin: The Importance of Causality Assessment.
    Mullins C; Beaulac K; Sylvia L
    Ann Pharmacother; 2020 Jun; 54(6):526-532. PubMed ID: 31786964
    [No Abstract]   [Full Text] [Related]  

  • 40. ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury.
    Chalasani NP; Maddur H; Russo MW; Wong RJ; Reddy KR;
    Am J Gastroenterol; 2021 May; 116(5):878-898. PubMed ID: 33929376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.